Business
Total Voting Rights
Total Voting Rights.
About this update from Sdi Group Plc
RNS Number : 8113N SDI Group PLC 01 October 2021 SDI Group plc ("SDI", the "Company", or the "Group") Total Voting Rights SDI Group plc, the AIM quoted group focused on the design and manufacture of scientific and technology products for use in digital imaging and sensing and control applications, announces that the total number of ordinary shares of 1 penny each ("Ordinary Shares") in issue is 99,558,164 and there are no Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares with voting rights in the Company is 99,558,164 . The above figure of 99,558,164 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules. Enquiries SDI Group plc 01223 727144 Ken Ford, Chairman Mike Creedon, CEO Jon Abell, CFO finnCap Ltd 020 7220 0500 Ed Frisby/Kate Bannatyne/Milesh Hindocha - Corporate Finance Andrew Burdis/Sunila de Silva - ECM JW Communications 07818 430 877 Julia Wilson - Investor & Public Relations About SDI Group plc: SDI designs and manufactures scientific and technology products for use in digital imaging and sensing and control applications including life sciences, healthcare, astronomy, manufacturing, precision optics and art conservation. SDI operates through its company divisions: Atik Cameras, Synoptics, Graticules Optics, Sentek, Astles Control Systems, Applied Thermal Control, MPB Industries, Chell Instruments and Monmouth Scientific. SDI continues to grow by developing its own technology advancements and by improving its global sales channels, as well as through pursuing strategic, complementary acquisitions. www.thesdigroup.net This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com . RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy . END TVRDKDBDABDDKKK